NCT05661604已完成不适用
Prospective Study to Investigate Acute Respiratory Virus Infections in Patients at High Risk for Severe Illness
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 140
- 试验地点
- 4
- 主要终点
- Number of Clinically Confirmed ARI Participants With Positive or Negative Infection Status for Each Respiratory Virus Tested
研究概览
简要总结
The purpose of the study is to describe the rate of occurrence of clinical diagnosis of acute respiratory infection (an infection that affects normal breathing) and different types of respiratory pathogens (harmful organisms) of new respiratory infections in a population at high risk for severe illness.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Must sign an informed consent form (ICF) indicating understanding the purpose, procedures, and potential risks and benefits of the study, and is willing to participate in the study
- •Participants at high risk for severe respiratory infections due to their immune-suppressive status and who fit in one or more of the following categories: a) Participants with hematologic malignancy (HM) including, but not limited to, acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), acute lymphoblastic leukemia (ALL), multiple myeloma (MM): i) Newly diagnosed, within 6 months of treatment initiation; including anticipation of cytotoxic and immunomodulatory therapy such as chimeric antigen receptor T (CAR-T) ii) Hematologic relapse within 6 months from anticipating treatment initiation for relapse iii) Participants with a history of HM who have maintained the immunosuppressive status in the opinion of the investigator and after consultation with the sponsor (that is, study responsible physician or scientists) b) Participants with a history of HM who have received hematopoietic cell transplant (HCT) within 1 year for autologous recipients or within 3 years for allogeneic recipients. c) Participants with a non-HM who have received HCT within 1 year for autologous recipients or within 3 years for allogeneic recipients. This can include, but is not limited to, participants who have received HCT due to lymphoproliferative disorders, solid tumors, primary immunodeficiency, bone marrow failure syndromes, hemoglobinopathies, sickle cell disease, or autoimmune disorders. d) Participants who have developed chronic graft vs host disease (GVHD) after HCT and are currently on immunosuppressive therapy
- •Must be able to read, understand, and complete questionnaires
- •Must be willing and able to connect current electronic health records from one or more providers
排除标准
- •Has a clinical condition other than those specified in inclusion criterion 3 which, in the opinion of the investigator, could prevent, confound, or limit the protocol-specified assessments (for example, asthma and allergies)
- •Is, in the opinion of the investigator, unlikely to adhere to the requirements of the study or is unlikely to complete the full course of observation
- •Cannot communicate reliably with the investigator
- •Has moderate-severe allergies that add complexity to the assessment of acute respiratory infection (ARI) episode
- •Is currently enrolled in an interventional study that could interfere with the assessment of respiratory viral dynamics
结局指标
主要结局
Number of Clinically Confirmed ARI Participants With Positive or Negative Infection Status for Each Respiratory Virus Tested
时间窗: Up to 1 year 3 months
Number of clinically confirmed ARI participants with positive or negative infection status for each respiratory virus tested will be reported.
Number of Participants with Clinically Confirmed Acute Respiratory Infection (ARI)
时间窗: Up to 1 year 3 months
Number of participants with clinically confirmed ARI will be reported.
次要结局
- Number of Clinically Confirmed ARI Participants who Were Hospitalized(Up to 1 year 3 months)
- Number of Clinically Confirmed ARI Participants who Experienced Complications(Up to 1 year 3 months)
- Number of Deaths in Clinically Confirmed ARI Participants(Up to 1 year 3 months)
研究者
研究点 (4)
Loading locations...
相似试验
已完成
不适用
An Observational Study to Assess RSV-associated Illness in Adults With COPD and/or CHFRespiratory Syncytial Virus, Chronic Obstructive Pulmonary Disease, Congestive Heart FailureNCT01455402MedImmune LLC476
已完成
不适用
Etiology and Outcomes of Tropical Acute Respiratory Distress SyndromeAcute Respiratory Distress SyndromeNCT01450527All India Institute of Medical Sciences, New Delhi64
已完成
不适用
Epidemiology of Respiratory Insufficiency in Critical CareAcute Respiratory FailureNCT01268410Hospital Sirio-Libanes773
已完成
不适用
Course and Complications of Invasive Out-of-hospital VentilationIndication for Invasive Out-of-hospital VentilationNCT01755039Wissenschaftliches Institut Bethanien e.V59
尚未招募
不适用
A prospective cohort study of acute respiratory failure in idiopathic interstitial pneumoniasIdiopathic interstitial pneumonias (IIPs)JPRN-UMIN000032940Tokai University School of Medicine50